-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O1.6 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Immunotherapy Clinically Relevant Abstract

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological therapies, Clinical Practice (Health Services and Quality), Lymphomas, Bispecific Antibody Therapy, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, indolent lymphoma, Therapies, Lymphoid Malignancies
Sunday, December 10, 2023: 4:30 PM-6:00 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Marco Ladetto, Universita di Torino Dipt. di Medicina en Oncologia and Eva Gine, MD, Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona
Ladetto: abbvie: Honoraria; Amgen: Honoraria; ADC Therapeutics: Research Funding; SOBI: Honoraria; beiGene: Honoraria, Research Funding; BMS/Celgene: Honoraria; EusaPharma: Honoraria; GSK: Honoraria; Gentili: Honoraria; Gilead/Kite: Honoraria; Novartis: Honoraria; Incyte: Honoraria; J&J: Honoraria, Research Funding; AstraZeneca: Honoraria, Research Funding; jazz: Honoraria; Lilly: Honoraria; Regeneron: Honoraria, Other: DSMC; Roche: Honoraria, Research Funding. Gine: Gilead: Consultancy, Honoraria; Miltenyi: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Research Funding; Genmab: Consultancy, Honoraria; Lilly: Consultancy, Honoraria.
4:30 PM

Stephen J Schuster, MD1, Nathan Fowler, MD2,3, Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA4, Joaquin Martinez-Lopez, MD, PhD5*, Arne Kolstad, MD, PhD6*, Jason Butler, MBBS7*, Monalisa Ghosh, MD8, Leslie L. Popplewell, MD, FACP, MPH9, Julio C Chavez, MD10, Emmanuel Bachy, MD, PhD11*, Koji Kato, M.D., Ph.D.12*, Hideo Harigae13, Marie José Kersten, MD, PhD14, Charalambos Andreadis15*, Peter A Riedell16*, Phoebe Joy Ho, MBBS, FRACP, FRCPA17, Jose A. Perez-Simon, MD, PhD18*, Andy Chen, MD, PhD19, Loretta J. Nastoupil, MD2, Bastian von Tresckow, MD20,21, Andrés José María Ferreri, MD22, Takanori Teshima23*, Piers Patten, FRCP, FRCPath, PhD24, Joseph P McGuirk, DO25, Andreas L Petzer, MD26*, Fritz Offner, MD27, Andreas Viardot, MD PhD28, Pier Luigi Zinzani, MD, PhD29,30, Ram Malladi, PhD31*, Aiesha Zia32*, Rakesh Awasthi, PhD33*, Ines Paule32*, Davide Germano32*, Roberto Javier Ramos, MD34*, Pei Hsu35*, Catherine Thieblemont, MD36* and Martin Dreyling, MD37

1Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2The University of Texas MD Anderson Cancer Center, Houston, TX
3BostonGene, Corp., Waltham, MA
4Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia
5Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
6Oslo University Hospital, Oslo, Norway
7Royal Brisbane Hospital, Herston, QLD, Australia
8Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
9Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
10Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
11Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France
12Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
13Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
14Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
15Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
16David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
17Royal Prince Alfred Hospital, Sydney, AUS
18Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
19Oregon Health and Science University, Portland, OR
20Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
21Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
22Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
23Department of Hematology, Hokkaido University, Sapporo, Japan
24King’s College London, London, GBR
25University of Kansas Medical Center, Westwood, KS
26Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria
27Universitair Ziekenhuis Gent, Gent, Belgium
28Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
29Universitaria di Bologna, Istituto Di Ematologia, Bologna, ITA
30Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
31Hospitals NHS Foundation Trust, Cambridge University, Cambridge, United Kingdom
32Novartis Pharma AG, Basel, CHE
33Novartis Pharmaceuticals, East Hanover, NJ
34Novartis Pharmaceuticals Corporation, East Hanover, NJ
35Novartis Pharma AG, Basel, Switzerland
36Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France
37Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany

4:45 PM

Franck Morschhauser, phd1, Saurabh Dahiya2*, Maria Lia Palomba, MD3, Alejandro Martin Garcia-Sancho, MD4*, Juan Luis Reguera, MD5,6*, John Kuruvilla, MD, FRCPC7, Ulrich Jaeger, MD8*, Guillaume Cartron, MD, Ph-D9*, Koji Izutsu, MD, PhD10, Martin Dreyling, MD11, Brad S. Kahl, MD12, Herve Ghesquieres, MD13*, Kirit Ardeshna, MD, MA, FRCP14*, Hideki Goto, MD, PhD15*, Anna Maria Barbui, MD16*, Jeremy S. Abramson, MD17, Peter Borchmann, MD18, Isabelle Fleury, MD19, Stephan Mielke, MD20, Alan Skarbnik, MD21,22, Sven de Vos, MD, PhD23*, Manali Kamdar, MD24*, Reem Karmali, MD, MSc25, Andreas Viardot, MD PhD26, Thalia Farazi27, Omotayo Fasan28, James Lymp, PhD29*, Min Vedal, PhD29*, Rina Nishii, PhD28*, Ariel Avilion, PhD29*, Jessica Papuga, PhD30* and Loretta J. Nastoupil, MD31

1CHU de Lille, Lille, France
2Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
5University Hospital Virgen del Rocío, Sevilla, Spain
6Instituto de Biomedicina de Sevilla (IBIS), Servicio de Hematología, Hospital Universitario Virgen del Rocío and Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain
7Princess Margaret Cancer Centre, Toronto, ON, Canada
8Medical University of Vienna, Vienna, Austria
9Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
10National Cancer Center Hospital, Tokyo, Japan
11Medizinische Klinik III, Klinikum der Universität, LMU München, Munich, Germany
12Washington University School of Medicine in St. Louis, St. Louis, MO
13Hôpital Lyon Sud, Lyon, France
14University College London Hospitals NHS Foundation Trust - University College Hospital, London, United Kingdom
15Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
16Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
17Massachusetts General Hospital Cancer Center, Boston, MA
18Universität zu Köln, Köln, Germany
19Hôpital Maisonneuve – Rosemont, Montreal, QC, Canada
20Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Stockholm, Sweden
21Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, NC
22Novant Health Cancer Institute, Charlotte, NC
23UCLA Santa Monica Medical Centre, Santa Monica, CA
24University of Colorado Cancer Center, Aurora, CO
25Northwestern University Feinberg School of Medicine, Chicago, IL
26Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
27Bristol Myers Squibb, San Francisco, CA
28Bristol Myers Squibb, Princeton, NJ
29Bristol Myers Squibb, Seattle, WA
30Bristol Myers Squibb, Boudry, Switzerland
31The University of Texas MD Anderson Cancer Center, Houston, TX

5:00 PM

Stephen J. Schuster, MD1, Laurie H. Sehn, MD, MPH2, Nancy L. Bartlett, MD3, Matthew Matasar, MD, MS4, Sarit Assouline, MD5, Pratyush Giri, MBBS6*, John Kuruvilla, MD7*, Mazyar Shadman, MD, MPH8*, Chan Y. Cheah, MBBS9,10, Sascha Dietrich, MD11*, Keith Fay, MBChB, FRACP, FRCPA12*, Matthew Ku, MBBS13*, Loretta J. Nastoupil, MD14, Michael C. Wei, MD, PhD15, Shen Yin, PhD15*, Iris To, PharmD15*, Jiangeng Huang, PhD15*, Antonia Kwan, MBBS, PhD15*, Elicia Penuel, PhD15 and Elizabeth Lihua Elizabeth Budde, MD, PhD16

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
4Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
5Jewish General Hospital, Montreal, QC, Canada
6Royal Adelaide Hospital, Adelaide, Australia
7Princess Margaret Cancer Centre, Toronto, ON, Canada
8Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
9The University of Western Australia, Perth, Australia
10Linear Clinical Research, Sir Charles Gairdner Hospital, Nedlands, Australia
11Heidelberg University Hospital, Heidelberg, Germany
12St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
13St Vincent's Hospital, University of Melbourne, Melbourne, Australia
14MD Anderson Cancer Center, Houston, TX
15Genentech, Inc., South San Francisco, CA
16City of Hope National Medical Center, Duarte, CA

5:15 PM

Lorenzo Falchi, MD1, Michelle Okwali, MPH1*, Paola Ghione, MD, MSEpi2, Colette Owens, MD3, Paul A. Hamlin, MD1, Jennifer Kimberly Lue, MD3, Zachary D. Epstein-Peterson, MD3, Maria Lia Palomba, MD1, Anita Kumar, MD2, Pallawi Torka, MD3, Lori A. Leslie, MD4, Alexandra Ferreira Lopes, BS2*, Anastasia Martinova, BSN, RN5*, Lauren Wood, MSN, RN, AGCNS-BC, OCN5*, Clare Grieve, MPH2*, Walter Ramos Amador, MPH, MS2*, Santosha A Vardhana, MD, PhD1*, Andrew D. Zelenetz, MD, PhD3 and Gilles Salles, MD, PhD3

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
2Memorial Sloan Kettering Cancer Center, New York, NY
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
5Memorial Sloan Kettering Cancer Center, New York

5:30 PM

Franck Morschhauser, MD PhD1, Krish Patel2*, Sabela Bobillo, MD, PhD3*, Raul Cordoba, MD, PhD4, Toby A. Eyre5*, Mark Bishton, MD, PhD6*, Roch Houot, MD, PhD7*, Hui-Lai Zhang, MD8*, Liqun Zou, MD, PhD9*, Wendy Osborne, MD10*, Laura Gálvez-Carvajal, MD, PhD11*, Catherine Thieblemont, MD12*, Donald Yee, MD13*, Andrea Knapp, PhD14*, Enkhtsetseg Purev, MD, PhD13*, Haocheng Li, PhD15*, Vivian Chen, PharmD13*, Karl L. Banta, PhD13*, Jason Sit, PharmD, PhD13* and Emmanuel Bachy, MD, PhD16*

1University of Lille, CHU Lille, Lille, France
2Swedish Cancer Institute, Seattle, WA
3Hospital Universitario Valle de Hebrón, Barcelona, Spain
4Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
5Oxford University Hospitals NHS Trust, Oxford, United Kingdom
6Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
7CHU de Rennes, Université de Rennes, INSERM U1236, EFS, Rennes, France
8Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
9West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
10Freeman Hospital, Newcastle upon Tyne, United Kingdom
11Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Malaga, Spain
12Hôpital Saint-Louis, Paris, France
13Genentech, Inc., South San Francisco, CA
14F. Hoffmann-La Roche Ltd, Basel, Switzerland
15Hoffmann-La Roche Limited, Mississauga, ON, Canada
16Department of Hematology, Hospices Civils de Lyon, Lyon, France

5:45 PM

Jonathan W. Friedberg, MD, MMSc1, Michael T. Brady2*, Strawderman Myla, MS3*, Brad S. Kahl, MD4, Izidore S. Lossos, MD5, Jonathon B. Cohen, MD, MS6, Patrick M. Reagan, MD7, Carla Casulo, MD2, Barbara L. Averill, BSN, RN8*, Brian K. Link, MD9*, Paul M. Barr, MD7, John P. Leonard10, John M. Ashton, PhD, MBA7*, Derick R Peterson, PhD11* and Loretta J. Nastoupil, MD12

1University of Rochester, Rochester, NY
2Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
3Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY
4Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
5Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
6Winship Cancer Institute, Emory University, Atlanta, GA
7Wilmot Cancer Institute, University of Rochester, Rochester, NY
8Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
9Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
10Weill Cornell Medicine, New York, NY
11Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY
12MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH